arginine and epirubicin

arginine has been researched along with epirubicin in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (25.00)18.2507
2000's7 (43.75)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hayashi, N; Ishii, Y; Muramatsu, I; Sakai, T1
Hao, Z; Weng, N; Xiao, B1
Li, G; Liu, F; Yang, Y; Zhang, L; Zhou, Y1
Pharoah, M; Thorner, P; Wang, CL; Yacobi, R1
Austin, CA; Capranico, G; Cornarotti, M; Fisher, LM; Tinelli, S; Willmore, E; Zunino, F1
Borgnetto, ME; Capranico, G; Carminati, L; Tinelli, S1
Dombernowsky, P; Hansen, HH; Hirsch, FR; Ingeberg, S; Jeppesen, N; Kristensen, C; Osterlind, K; Sorensen, PG1
Yao, H; Zhou, J; Zhu, Q1
Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A1
Seiter, K1
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A1
Marik, PE; Vahid, B1

Reviews

4 review(s) available for arginine and epirubicin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC).
    Journal of separation science, 2008, Volume: 31, Issue:9

    Topics: Arginine; Choline; Chromatography, Liquid; Daunorubicin; Epirubicin; Glycine; Hydrogen Bonding; Phase Transition; Silicon Dioxide; Solvents; Tandem Mass Spectrometry; Temperature; Water

2008
Toxicity of the topoisomerase II inhibitors.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases

2005
Pulmonary complications of novel antineoplastic agents for solid tumors.
    Chest, 2008, Volume: 133, Issue:2

    Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bevacizumab; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Everolimus; Gemcitabine; Humans; Lung; Lung Diseases; Mitoxantrone; Neoplasms; Pneumonia; Pyrimidines; Risk Factors; Sirolimus; Teniposide; Trastuzumab

2008

Trials

3 trial(s) available for arginine and epirubicin

ArticleYear
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Mesna; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine

2001
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-20, Volume: 23, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine

2005
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jul-01, Volume: 23, Issue:19

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine

2005

Other Studies

9 other study(ies) available for arginine and epirubicin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Inhibition of NO synthase induction by an anticancer drug 4'-epi-doxorubicin in rats.
    General pharmacology, 1996, Volume: 27, Issue:8

    Topics: Acetylcholine; Animals; Antibiotics, Antineoplastic; Aorta, Thoracic; Arginine; Cerebellum; Citrulline; Endothelium, Vascular; Enzyme Induction; Epirubicin; In Vitro Techniques; Lipopolysaccharides; Lung; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroprusside; Rats; Rats, Wistar

1996
Twin-Arginine Translocation Peptide Conjugated Epirubicin-Loaded Nanoparticles for Enhanced Tumor Penetrating and Targeting.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:12

    Topics: Animals; Arginine; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Carriers; Drug Delivery Systems; Epirubicin; Humans; Mice; Nanoparticles; Neoplasms; Rats; Tissue Distribution; Twin-Arginine-Translocation System

2015
Ewing's sarcoma: metastatic tumor to the jaw.
    Oral surgery, oral medicine, and oral pathology, 1991, Volume: 71, Issue:5

    Topics: Carboplatin; Child; Dacarbazine; Epirubicin; Female; Humans; Mandibular Neoplasms; Radiography; Sarcoma, Ewing; Teniposide; Thoracic Neoplasms

1991
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).
    Molecular pharmacology, 1996, Volume: 50, Issue:6

    Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Humans; Isoenzymes; Mice; Recombinant Proteins; Substrate Specificity; Teniposide

1996
Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
    Journal of molecular biology, 1999, Jan-15, Volume: 285, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Cell Line; Diterpenes; DNA; DNA Topoisomerases, Type II; Drosophila melanogaster; Enzyme Inhibitors; Epirubicin; Genes, Insect; Histones; Molecular Sequence Data; Poisons; Teniposide; Transcription, Genetic

1999
[Chemotherapy of non-small-cell lung cancer (NSCLC) and changes in serum sAPO-1/Fas and nitric oxide (NO) levels].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; fas Receptor; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitric Oxide; Teniposide; Treatment Outcome

2000